Whoa, Schrödinger just pulled the plug on their new blood cancer drug after two patients died during early testing. The drug, SGR-2921, was supposed to help people with tough-to-treat blood cancers, but it ended up being linked to the deaths. The company said it’s a tough call, but stopping the trial is the safest move for patients. Shares dropped almost 17% after the news broke. Science is wild, but sometimes the risks are just too high. #Health #BodyHealth #biotech